Repurposing anticancer drugs for targeting necroptosis.

about

Repurposing anticancer drugs for targeting necroptosis.

Item

http://www.wikidata.org/entity/Q49717299

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Repurposing anticancer drugs for targeting necroptosis.

@en

Repurposing anticancer drugs for targeting necroptosis.

@nl

type

Item

label

Repurposing anticancer drugs for targeting necroptosis.

@en

Repurposing anticancer drugs for targeting necroptosis.

@nl

prefLabel

Repurposing anticancer drugs for targeting necroptosis.

@en

Repurposing anticancer drugs for targeting necroptosis.

@nl

P1476

Repurposing anticancer drugs for targeting necroptosis.

@en

P2860

Structural basis of RIP1 inhibition by necrostatins

AP24534, a pan-BCR-ABL inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and overcomes mutation-based resistance

Structural mechanism of the Pan-BCR-ABL inhibitor ponatinib (AP24534): lessons for overcoming kinase inhibitor resistance

Ponatinib in refractory Philadelphia chromosome-positive leukemias.

Drug repositioning: identifying and developing new uses for existing drugs

Molecular mechanisms of necroptosis: an ordered cellular explosion

A cellular screen identifies ponatinib and pazopanib as inhibitors of necroptosis.

Essential versus accessory aspects of cell death: recommendations of the NCCD 2015.

Regulated necrosis: the expanding network of non-apoptotic cell death pathways.

Necroptosis

P304

1-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/15384101.2018.1442626

http://www.w3.org/2001/XMLSchema#string

P50

Simone Fulda

P577

2018-02-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29464983

http://www.w3.org/2001/XMLSchema#string

P921

necroptosis

P932

6056208

http://www.w3.org/2001/XMLSchema#string